GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal

GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014. On Thursday, GSK said Tesaro has filed a ...